Following this screening process, 19 studies were identified as relevant to the topic of short peptides and oral cavity
Defining the Triple Agonist Mechanism Retatrutide is a synthetic investigational peptide designed to activate three hormone receptors: glucose-dependent insulinotropic polypeptide (GIP), glucagon-like peptide-1 (GLP-1), and glucagon
The mechanism of action, involving natural beta-3 adrenergic receptors and lipolytic pathways, suggests that chronic use is unlikely to produce novel safety concerns beyond what was observed in clinical trials
Musculoskeletal Repair: Studies have explored its potential in tendon and ligament repair, cartilage regeneration, and osteogenic processes, with preliminary evidence suggesting improved tissue regeneration in animal models
Neither compound should be considered a licensed medicine in the UK, and both require careful scrutiny before any consideration of use